DNA methyltransferase inhibitor CDA-2 synergizes with high-dose thiotepa and paclitaxel in killing breast cancer stem cells

10.2741/e239 ◽  
2011 ◽  
Vol E3 (1) ◽  
pp. 240-249 ◽  
Author(s):  
Jun Ren
Keyword(s):  
Breast Cancer ◽  
Stem Cells ◽  
Cancer Stem Cells ◽  
Dna Methyltransferase ◽  
High Dose ◽  
Breast Cancer Stem Cells ◽  
Dna Methyltransferase Inhibitor

scholarly journals Author Correction: Glycosphingolipid expression at breast cancer stem cells after novel thieno[2,3-b]pyridine anticancer compound treatment

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Sandra Marijan ◽  
Anita Markotić ◽  
Angela Mastelić ◽  
Nikolina Režić-Mužinić ◽  
Lisa Ivy Pilkington ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Stem Cells ◽  
Cancer Stem Cells ◽  
Breast Cancer Stem Cells ◽  
Anticancer Compound

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

scholarly journals Targeting the Roots of Recurrence: New Strategies for Eliminating Therapy-Resistant Breast Cancer Stem Cells

Cancers ◽  
2020 ◽  
Vol 13 (1) ◽  
pp. 54
Author(s):  
Margaret L. Dahn ◽  
Paola Marcato
Keyword(s):  
Breast Cancer ◽  
Stem Cells ◽  
Cancer Stem Cells ◽  
Breast Cancer Stem Cells ◽  
Self Renewal ◽  
New Strategies

Cancer stem cells (CSCs) are functionally defined in our laboratories by their impressive tumor-generating and self-renewal capacity; clinically, CSCs are of interest because of their enhanced capacity to evade conventional therapies [...]

Sign in / Sign up

Export Citation Format

Share Document